Annual Total Expenses
$18.83 B
+$4.35 B+30.03%
31 December 2023
Summary:
Novo Nordisk A/S annual total expenses is currently $18.83 billion, with the most recent change of +$4.35 billion (+30.03%) on 31 December 2023. During the last 3 years, it has risen by +$7.67 billion (+68.75%). NVO annual total expenses is now at all-time high.NVO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$5.52 B
-$555.83 M-9.14%
30 September 2024
Summary:
Novo Nordisk A/S quarterly total expenses is currently $5.52 billion, with the most recent change of -$555.83 million (-9.14%) on 30 September 2024. Over the past year, it has increased by +$878.31 million (+18.90%). NVO quarterly total expenses is now -9.14% below its all-time high of $6.08 billion, reached on 30 June 2024.NVO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.0% | +18.9% |
| 3 y3 years | +68.8% | +71.0% |
| 5 y5 years | +84.0% | +113.7% |
NVO Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +68.8% | -9.1% | +71.0% |
| 5 y | 5 years | at high | +84.0% | -9.1% | +131.4% |
| alltime | all time | at high | +5977.4% | -9.1% | +3837.0% |
Novo Nordisk A/S Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.52 B(-9.1%) |
| June 2024 | - | $6.08 B(+24.6%) |
| Mar 2024 | - | $4.88 B(-13.5%) |
| Dec 2023 | $18.83 B(+30.0%) | $5.64 B(+21.4%) |
| Sept 2023 | - | $4.65 B(+4.5%) |
| June 2023 | - | $4.44 B(+8.7%) |
| Mar 2023 | - | $4.09 B(-4.0%) |
| Dec 2022 | $14.48 B(+10.8%) | $4.26 B(+24.0%) |
| Sept 2022 | - | $3.44 B(+4.9%) |
| June 2022 | - | $3.27 B(-5.1%) |
| Mar 2022 | - | $3.45 B(-9.1%) |
| Dec 2021 | $13.07 B(+17.2%) | $3.80 B(+17.6%) |
| Sept 2021 | - | $3.23 B(+9.1%) |
| June 2021 | - | $2.96 B(-3.0%) |
| Mar 2021 | - | $3.05 B(-9.1%) |
| Dec 2020 | $11.16 B(+7.0%) | $3.36 B(+18.0%) |
| Sept 2020 | - | $2.85 B(+19.2%) |
| June 2020 | - | $2.39 B(-8.0%) |
| Mar 2020 | - | $2.59 B(-14.8%) |
| Dec 2019 | $10.43 B(+1.9%) | $3.05 B(+17.8%) |
| Sept 2019 | - | $2.59 B(+3.6%) |
| June 2019 | - | $2.50 B(+8.9%) |
| Mar 2019 | - | $2.29 B(-20.9%) |
| Dec 2018 | $10.23 B(+7.1%) | $2.90 B(+16.5%) |
| Sept 2018 | - | $2.49 B(+2.1%) |
| June 2018 | - | $2.44 B(+2.0%) |
| Mar 2018 | - | $2.39 B(-15.9%) |
| Dec 2017 | $9.55 B(+1.4%) | $2.84 B(+23.3%) |
| Sept 2017 | - | $2.30 B(+2.1%) |
| June 2017 | - | $2.26 B(+5.2%) |
| Mar 2017 | - | $2.14 B(-19.5%) |
| Dec 2016 | $9.42 B(+8.2%) | $2.66 B(+17.5%) |
| Sept 2016 | - | $2.27 B(-0.2%) |
| June 2016 | - | $2.27 B(+3.1%) |
| Mar 2016 | - | $2.20 B(-15.4%) |
| Dec 2015 | $8.70 B(-10.2%) | $2.60 B(+18.0%) |
| Sept 2015 | - | $2.21 B(+2.2%) |
| June 2015 | - | $2.16 B(+25.6%) |
| Mar 2015 | - | $1.72 B(-33.6%) |
| Dec 2014 | $9.69 B(+4.5%) | $2.59 B(+6.4%) |
| Sept 2014 | - | $2.43 B(+2.6%) |
| June 2014 | - | $2.37 B(+4.9%) |
| Mar 2014 | - | $2.26 B(-13.7%) |
| Dec 2013 | $9.27 B(+10.6%) | $2.62 B(+17.7%) |
| Sept 2013 | - | $2.22 B(-0.7%) |
| June 2013 | - | $2.24 B(+2.0%) |
| Mar 2013 | - | $2.20 B(-5.6%) |
| Dec 2012 | $8.38 B(+2.1%) | $2.33 B(+15.8%) |
| Sept 2012 | - | $2.01 B(-1.4%) |
| June 2012 | - | $2.04 B(+1.8%) |
| Mar 2012 | - | $2.00 B(-5.3%) |
| Dec 2011 | $8.21 B | $2.12 B(+1.2%) |
| Sept 2011 | - | $2.09 B(+0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2011 | - | $2.07 B(+8.3%) |
| Mar 2011 | - | $1.91 B(-10.9%) |
| Dec 2010 | $7.46 B(+11.3%) | $2.15 B(+18.3%) |
| Sept 2010 | - | $1.81 B(+2.5%) |
| June 2010 | - | $1.77 B(-0.0%) |
| Mar 2010 | - | $1.77 B(-2.1%) |
| Dec 2009 | $6.70 B(+2.3%) | $1.81 B(+7.2%) |
| Sept 2009 | - | $1.68 B(+3.3%) |
| June 2009 | - | $1.63 B(+7.1%) |
| Mar 2009 | - | $1.52 B(-7.2%) |
| Dec 2008 | $6.55 B(+8.2%) | $1.64 B(+2.9%) |
| Sept 2008 | - | $1.59 B(-7.9%) |
| June 2008 | - | $1.73 B(+10.6%) |
| Mar 2008 | - | $1.56 B(-18.4%) |
| Dec 2007 | $6.06 B(+21.3%) | $1.92 B(+32.7%) |
| Sept 2007 | - | $1.44 B(+2.9%) |
| June 2007 | - | $1.40 B(+6.5%) |
| Mar 2007 | - | $1.32 B(-9.1%) |
| Dec 2006 | $4.99 B(+16.5%) | $1.45 B(+19.8%) |
| Sept 2006 | - | $1.21 B(+1.1%) |
| June 2006 | - | $1.20 B(+5.1%) |
| Mar 2006 | - | $1.14 B(-4.5%) |
| Dec 2005 | $4.28 B(+15.3%) | $1.19 B(+12.4%) |
| Sept 2005 | - | $1.06 B(+5.8%) |
| June 2005 | - | $1.00 B(-1.2%) |
| Mar 2005 | - | $1.01 B(-7.3%) |
| Dec 2004 | $3.71 B(+20.7%) | $1.09 B(+17.6%) |
| Sept 2004 | - | $930.23 M(+8.8%) |
| June 2004 | - | $854.69 M(+1.6%) |
| Mar 2004 | - | $841.19 M(-69.4%) |
| Dec 2003 | $3.08 B(+26.1%) | $2.75 B(+1632.0%) |
| Sept 2003 | - | $158.89 M(+3.7%) |
| June 2003 | - | $153.19 M(+9.2%) |
| Mar 2003 | - | $140.33 M |
| Dec 2002 | $2.44 B(+12.1%) | - |
| Dec 2001 | $2.18 B(+6.0%) | - |
| Dec 2000 | $2.05 B(+5.9%) | - |
| Dec 1999 | $1.94 B(+6.2%) | - |
| Dec 1998 | $1.83 B(-17.8%) | - |
| Dec 1997 | $2.22 B(-0.3%) | - |
| Dec 1996 | $2.23 B(+5.4%) | - |
| Dec 1995 | $2.11 B(+14.9%) | - |
| Dec 1994 | $1.84 B(+6.4%) | - |
| Dec 1993 | $1.73 B(+9.5%) | - |
| Dec 1992 | $1.58 B(+19.6%) | - |
| Dec 1991 | $1.32 B(+12.0%) | - |
| Dec 1990 | $1.18 B(+31.0%) | - |
| Dec 1989 | $900.04 M(+28.8%) | - |
| Dec 1988 | $698.77 M(+9.0%) | - |
| Dec 1987 | $641.08 M(+47.0%) | - |
| Dec 1986 | $436.13 M(+33.9%) | - |
| Dec 1985 | $325.82 M(+5.2%) | - |
| Dec 1984 | $309.82 M | - |
FAQ
- What is Novo Nordisk A/S annual total expenses?
- What is the all time high annual total expenses for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual total expenses year-on-year change?
- What is Novo Nordisk A/S quarterly total expenses?
- What is the all time high quarterly total expenses for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly total expenses year-on-year change?
What is Novo Nordisk A/S annual total expenses?
The current annual total expenses of NVO is $18.83 B
What is the all time high annual total expenses for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total expenses is $18.83 B
What is Novo Nordisk A/S annual total expenses year-on-year change?
Over the past year, NVO annual total expenses has changed by +$4.35 B (+30.03%)
What is Novo Nordisk A/S quarterly total expenses?
The current quarterly total expenses of NVO is $5.52 B
What is the all time high quarterly total expenses for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total expenses is $6.08 B
What is Novo Nordisk A/S quarterly total expenses year-on-year change?
Over the past year, NVO quarterly total expenses has changed by +$878.31 M (+18.90%)